A detailed history of Vr Adviser, LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Vr Adviser, LLC holds 12,762,462 shares of OCUL stock, worth $109 Million. This represents 11.5% of its overall portfolio holdings.

Number of Shares
12,762,462
Previous 12,762,462 -0.0%
Holding current value
$109 Million
Previous $87.3 Million 27.19%
% of portfolio
11.5%
Previous 9.58%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $19.2 Million - $54.5 Million
4,986,702 Added 64.13%
12,762,462 $116 Million
Q4 2023

Feb 14, 2024

BUY
$2.08 - $4.52 $16.2 Million - $35.1 Million
7,775,760 New
7,775,760 $34.7 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $656M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.